MDEA Winner Shows the Value of Nonsurgical Robots in Healthcare

Equashield is proving that robots aren’t limited to just helping with surgeries in the healthcare industry. The Port Washington, N.Y.-based company and Gold winner for MDEA under the Non-Surgical and Hospital Supplies category has developed the Equashield Pro technology. The device is designed to help transport and handle dangerous drugs. The system enables compounding large varieties of patient-specific chemotherapy doses quickly, using optimized process flow by performing multiple tasks simultaneously. The Pro’s highly reliable dose verification software reduces the occurrences of medication dosage and identification errors when preparing hazardous drugs. “We switched from manual to automation and it took us several years,” Marino Kriheli, co-founder of Equashield, told MD+DI. “We knew exactly what we needed. “Our engineers were able to go into detail into how the automation was going to look.” Earlier this year, Equashield said it received its first purchase orders for its Equashield Pro closed system compounding robot. “When we introduced the Equashield Pro at ASHP in 2016, we received extremely positive feedback from pharmacy professionals. Since that time, we have refined and improved the safety and efficiency of the Pro, making it ready to enter healthcare facilities worldwide,” Kriheli said in a release. “Automation is the natural direction for the hazardous drug compounding industry, and the Pro, which utilizes our Equashield CSTD, is ready to pr...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Source Type: news